Overview of Emphysema and COPD Research Studies

 
MESA Lung/MESA COPD Report
 
 
 
 
 
R Graham Barr, MD DrPH
 
Departments of Medicine and Epidemiology
Columbia University Medical Center
 
 
 
 
Funding: NHLBI R01s HL077612, HL075476, HL093081
RC1 HL100543
 
Remember Sept 18
th
, 1314
Remember 1603
 
Outline
 
Design
Publications
Emphysema  ≠  COPD
The shrinking heart and lungs
Data availability
MESA Lung III / MESA Lung non-smokers
MESA COPD II
 
 
MESA Lung 
vs. 
MESA COPD
 
MESA Lung
3,965 ppts w/ spirometry, Exam 3-4, 5
3,205 ppts w/ full lung CT in Exam 5
%emphysema on all Exam 1, Family,
Air cardiac CTs
10 yr f/u of %emphysema in 3205 ppts
MESA COPD
Case control study of 325 ppts, Exam 5
 
Emphysema  ≠  COPD
 
Percent Emphysema in “Normals”
 
Hoffman, Annals ATS, 2014
 
N=854
(Exam 5)
 
GWAS for Percent Emphysema
 
Manichaikul, AJRCCM, 2014
- Lung
 
GWAS for Lung Function (FEV
1
/FVC)
Soler Artigas, Nat Gen 2010
Cheng, AJRCCM, 2013
Manichaikul, AJRCCM, 2014
n=94,612
1 m SNPs
AGER/
PPT
HHIP
 
Emphysema
genes
THSD4
 
GWAS for Percent Emphysema
 
Manichaikul, AJRCCM, 2014
 
MAN2B1
 
2113 Hispanics
 
subforms of alpha-mannosidase
 
rs10411619
 
Plasma α
1
 Antitrypsin level
 
P=0.01
- Lung
 
 
Emphysema in the General Population
 
Emphysema is common in older adults
Occurs mostly in patients with normal
lung function
Distinct genetic basis
Greater percent emphysema on CT in
MESA is associated with dyspnea,
reduced exercise tolerance, and
increased all cause mortality
 
Smaller Heart and Lungs
 
Classic Emphysema Subtypes on CT
 
Smith, Am J Med, 2014
 
None  Centrilobular Paraseptal Panlobular
n=205
 
         n=65
 
       n=33
 
  n=15
 
Body Mass Index (kg/m
2
)
 
* P<0.05
- Lung
 
 
%Emphysema and LV Measures
 
Adjusted for age, sex, race, education, packyears, cotinine, BSA, height, DM, FPG, HTN, SBP, DBP, CRP, fibrinogen
 
Barr,  NEJM, 2010
 
Pulmonary Vein Size in Emphysema
 
Smith, Chest, 2013
 
Total Pulmonary Vascular Volume
 
 
Right Ventricular Changes in COPD
 
Adjusted for age, gender, race/ethnicity, cohort, height, weight,
smoking status, pack-years, hypertension, sleep apnea and mAs
 
Kawut, JACC, in press
 
Smaller Airway Walls in COPD
 
Smith, Thorax, 2014
 
Smaller Airway Walls in COPD
 
Smith, Thorax, 2014
 
Small Heart and Lungs in COPD
 
COPD and particularly emphysema
Smaller LV, LA, pulmonary veins,
TPVV, and right ventricle
Smaller airways in COPD
Failure of cardiopulmonary function
 
 
Exam 5 (n~3,205)
Spirometry (+ post-bronchodilator if airflow limitation)
Percent emphysema and “emphysema” > ULN; HAA
Qualitative reads of emphysema subtype, interstitial
lung abnormalities
Airways
Total Pulmonary Vascular Volume
Urinary cotinine
Exam 1-4 (~all)
Percent emphysema and high attenuation areas
 
Data Availability – MESA Lung
 
Pulmonary microvascular blood volume
is reduced and total pulmonary artery
volume (TPAV) is increased in
panlobular emphysema
Summited 5/14
 
MESA Lung III
 
Examination of panlobular emphysema
in the general population
Possible submission 2/14
 
MESA Lung “Nonsmokers”
 
5:00
  
Introductions
5:10-5:25
 
Pulmonary Vasculature on CT and
 
  MRI and Systemic Blood Pressure
5:25-5:35
 
Scientific Output of MESA COPD
5:35-5:45
 
Aims of MESA COPD II
5:45-6:00
 
Protocol and Logistics
6:00-6:20
 
MRI +/- Echocardiography
6:20-6:35 
 
Pulmonary Vascular Volume on CT and
 
  Left Ventricular Filling
6:35 
  
Close
 
MESA COPD II
 
Acknowledgements
 
MESA Lung Study Investigators
  
MESA COPD Investigators
Columbia 
 
Firas Ahmed, MD MPH
 
John Austin, MD
  
   
 
Ben Smith, MD MS
 
Charles Powell, MD
  
   
 
Katie Donohue, MD MPH
 
Martin Prince, MD PhD
  
   
 
Dan Rabinowitz, PhD
 
David Bluemke, MD PhD
  
   
 
Steven Shea, MD MS
 
Daichi Shimbo, MD
Johns Hopkins
 
Wendy Post, MD 
  
Joao Lima, MD
Northwestern 
 
Kiang Liu, PhD
  
Steven Kawut, MD MPH
   
Lewis Smith, MD
  
Megha Parikh, MS
Wake Forest
 
Jeff Carr, MD MS
  
Katja Hueper, PhD
Univ Arizona
 
Paul Enright, MD
  
Jens Vogel-Claussen, MD PhD
Univ Iowa
 
Eric Hoffman, PhD
 
Andrew Laine, PhD
Univ Vermont
 
Russell Tracy, PhD
 
Elizabeth Oelsner, MD
Univ Washington
 
Richard Kronmal, PhD
 
Carrie Aaron, MD
   
Karen Hinckley, MS
 
Tess Pottinger, MS
UCLA 
  
Robert Detrano, MD PhD
 
Emlyn Hughes, PhD
   
Karol Watson, MD PhD 
 
Christian Lo Cascio, MD
Other
  
John Hankinson, PhD
- Lung
 
Slide Note
Embed
Share

Research conducted by Dr. R. Graham Barr and his team at Columbia University Medical Center focuses on emphysema and COPD, funded by NHLBI grants. The studies explore the genetic basis, prevalence in the general population, and impact on lung function and mortality. Various imaging techniques and genetic studies shed light on the link between emphysema, dyspnea, and reduced exercise tolerance, highlighting its significance in older adults even with normal lung function.

  • Emphysema
  • COPD
  • Research Studies
  • Lung Function
  • Genetics

Uploaded on Sep 25, 2024 | 1 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. MESA Lung/MESA COPD Report R Graham Barr, MD DrPH Departments of Medicine and Epidemiology Columbia University Medical Center Funding: NHLBI R01s HL077612, HL075476, HL093081 RC1 HL100543

  2. Remember Sept 18th, 1314

  3. Remember 1603

  4. Outline Design Publications Emphysema COPD The shrinking heart and lungs Data availability MESA Lung III / MESA Lung non-smokers MESA COPD II

  5. MESA Lung vs. MESA COPD MESA Lung 3,965 ppts w/ spirometry, Exam 3-4, 5 3,205 ppts w/ full lung CT in Exam 5 %emphysema on all Exam 1, Family, Air cardiac CTs 10 yr f/u of %emphysema in 3205 ppts MESA COPD Case control study of 325 ppts, Exam 5

  6. Emphysema COPD

  7. Percent Emphysema in Normals N=854 (Exam 5) Hoffman, Annals ATS, 2014

  8. GWAS for Percent Emphysema - Lung Manichaikul, AJRCCM, 2014

  9. GWAS for Lung Function (FEV1/FVC) HHIP Emphysema genes THSD4 AGER/ PPT n=94,612 1 m SNPs Soler Artigas, Nat Gen 2010 Cheng, AJRCCM, 2013 Manichaikul, AJRCCM, 2014

  10. GWAS for Percent Emphysema - Lung rs10411619 2113 Hispanics Plasma 1 Antitrypsin level P=0.01 MAN2B1 145 140 135 130 125 120 115 RS10411619 homozygotes Matched controls subforms of alpha-mannosidase Manichaikul, AJRCCM, 2014

  11. Emphysema in the General Population Emphysema is common in older adults Occurs mostly in patients with normal lung function Distinct genetic basis Greater percent emphysema on CT in MESA is associated with dyspnea, reduced exercise tolerance, and increased all cause mortality

  12. Smaller Heart and Lungs

  13. Classic Emphysema Subtypes on CT - Lung Body Mass Index (kg/m2) * P<0.05 None Centrilobular Paraseptal Panlobular n=205 n=65 n=33 n=15 Smith, Am J Med, 2014

  14. %Emphysema and LV Measures - Lung Change in cardiac measure per 0.10 increase in percent emphysema (95% CI) -4.1 (-4.9, -3.3) -1.4 (-1.9, -0.9) -2.7 (-3.3, -2.2) 0.0 (-0.2, 0.3) -0.19 (-0.23, -0.14) -2.5 (-3.4, -1.6) P-value LV End Diastolic Volume (ml) 10-16 LV End Systolic Volume (ml) 10-8 LV Stroke Volume (ml) 10-16 LV Ejection Fraction (%) 0.89 Cardiac Output (L/min) 10-14 LV Mass (g) 10-8 Adjusted for age, sex, race, education, packyears, cotinine, BSA, height, DM, FPG, HTN, SBP, DBP, CRP, fibrinogen Barr, NEJM, 2010

  15. Pulmonary Vein Size in Emphysema Smith, Chest, 2013

  16. Total Pulmonary Vascular Volume

  17. Right Ventricular Changes in COPD Controls (n=163) Mild (n=60) Moderate (n=67) Severe (n=20) P- Trend RV End Diastolic Volume, mL Unadjusted mean Minimally adjusted Fully adjusted RV End Diastolic Mass, g Unadjusted mean Minimally adjusted Fully adjusted 130.75 130.70 130.67 136.08 129.12 129.70 123.94 118.40* 118.94* 118.93 106.86* 0.003 107.58* 0.004 23.01 23.04 23.02 22.20 22.74 22.90 20.69 21.66 21.54 21.71 23.61 23.47 0.68 0.55 Adjusted for age, gender, race/ethnicity, cohort, height, weight, smoking status, pack-years, hypertension, sleep apnea and mAs Kawut, JACC, in press

  18. Smaller Airway Walls in COPD Smith, Thorax, 2014

  19. Smaller Airway Walls in COPD Smith, Thorax, 2014

  20. Small Heart and Lungs in COPD COPD and particularly emphysema Smaller LV, LA, pulmonary veins, TPVV, and right ventricle Smaller airways in COPD Failure of cardiopulmonary function

  21. Data Availability MESA Lung Exam 5 (n~3,205) Spirometry (+ post-bronchodilator if airflow limitation) Percent emphysema and emphysema > ULN; HAA Qualitative reads of emphysema subtype, interstitial lung abnormalities Airways Total Pulmonary Vascular Volume Urinary cotinine Exam 1-4 (~all) Percent emphysema and high attenuation areas

  22. MESA Lung III Pulmonary microvascular blood volume is reduced and total pulmonary artery volume (TPAV) is increased in panlobular emphysema Summited 5/14

  23. MESA Lung Nonsmokers Examination of panlobular emphysema in the general population Possible submission 2/14

  24. MESA COPD II 5:00 5:10-5:25 Pulmonary Vasculature on CT and MRI and Systemic Blood Pressure 5:25-5:35 Scientific Output of MESA COPD 5:35-5:45 Aims of MESA COPD II 5:45-6:00 Protocol and Logistics 6:00-6:20 MRI +/- Echocardiography 6:20-6:35 Pulmonary Vascular Volume on CT and Left Ventricular Filling 6:35 Close Introductions

  25. Acknowledgements - Lung MESA Lung Study Investigators Columbia Johns Hopkins Northwestern Wake Forest Univ Arizona Univ Iowa Univ Vermont Univ Washington Richard Kronmal, PhD Karen Hinckley, MS UCLA Robert Detrano, MD PhD Emlyn Hughes, PhD Karol Watson, MD PhD Other John Hankinson, PhD MESA COPD Investigators John Austin, MD Charles Powell, MD Firas Ahmed, MD MPH Ben Smith, MD MS Katie Donohue, MD MPH Martin Prince, MD PhD Dan Rabinowitz, PhD Steven Shea, MD MS Wendy Post, MD Kiang Liu, PhD Lewis Smith, MD Jeff Carr, MD MS Paul Enright, MD Eric Hoffman, PhD Russell Tracy, PhD David Bluemke, MD PhD Daichi Shimbo, MD Joao Lima, MD Steven Kawut, MD MPH Megha Parikh, MS Katja Hueper, PhD Jens Vogel-Claussen, MD PhD Andrew Laine, PhD Elizabeth Oelsner, MD Carrie Aaron, MD Tess Pottinger, MS Christian Lo Cascio, MD

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#